Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Manitex Capital Inc V.MNX

Healthcare
Manitex Capital Inc. is a Canada-based Diversified investment company. The Company is specialized in investing in emerging as well as established companies in diversified sectors, including life sciences and sustainable products/technologies. The Company also holds an extensive portfolio in marketable securities in companies in the same fields.

Recent & Breaking News (TSXV:MNX)

Manitex Capital Reports Annual Financial Results

Canada NewsWire February 28, 2024

Manitex Capital Announces Change of Auditor

Canada NewsWire October 12, 2023

Manitex Capital Announces Resignation of a Director and New Board Appointment

Canada NewsWire August 17, 2023

Manitex Capital Reports Annual Financial Results

Canada NewsWire February 24, 2023

Manitex Capital Reports Third Quarter Financial Results and Grants Options to its Officers

Canada NewsWire September 29, 2022

Manitex Capital Reports Second Quarter Financial Results and Grants Options to Certain Directors

Canada NewsWire June 29, 2022

Manitex Capital Inc. Restates Previously Reported Q1 2020 Quarterly Financial Results and Grants Options to Certain Directors

Canada NewsWire June 30, 2020

Early Warning Report Filed Pursuant To National Instrument 62-103

Canada NewsWire October 10, 2019

Manitex Capital Inc. Completes Distribution of Dividend-In-Kind Consisting of Warrants of Valeo Pharma Inc.

Canada NewsWire August 28, 2019

Manitex Capital Inc. declares a dividend-in-kind of warrants of Valeo Pharma Inc.

Canada NewsWire July 30, 2019

Manitex Capital Inc. announces results of AGM

Canada NewsWire April 5, 2019

Manitex Capital Inc.'s affiliate, Valeo Pharma Inc., announces approval of Onstryv® (safinamide) for Canada

Canada NewsWire January 15, 2019

Manitex Capital Inc. declares a dividend-in-kind of shares of Valeo Pharma Inc.

Canada NewsWire January 11, 2019

Manitex Capital Inc. announces director resignation

Canada NewsWire November 21, 2018

Manitex Capital Inc. Announces That Its Affiliate Valeo Pharma Inc. Has Filed a Non-Offering Preliminary Prospectus

Canada NewsWire October 1, 2018

Manitex Capital Inc. completes distribution of dividend-in-kind of shares of Auxico Resources Canada Inc.

Canada NewsWire October 12, 2017

Manitex Capital Inc. declares a dividend-in-kind of shares of Auxico Resources Canada Inc.

Canada NewsWire September 11, 2017

Manitex Capital Inc.'s affiliate, Valeo Pharma Inc., announces partnership for a Parkinson's disease treatment

Canada NewsWire April 11, 2017

Manitex Capital Inc. restates previously reported 2016 quarterly financial results

Canada NewsWire March 30, 2017

Manitex Capital Inc. adopts a new 20% fixed incentive stock option plan

Canada NewsWire March 2, 2017